ESC Professional Premium Access

ENTRIGUE: Pegozafermin for the treatment of severe hypertriglyceridemia.

Congress Presentation

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York (United States of America)
49 presentations
11 followers

3 more presentations in this session

Mechanisms of the clinical benefits of SGLT2i in heart failure (EMPEROR-Pooled)

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Lifetime prediction and Treatment Benefit in HFrEF (LIFE-HF).

Speaker: Doctor S. Koudstaal (Gouda, NL)

Thumbnail

Genotype-Guided Oral P2Y12 Inhibitor Therapy Reduces Cumulative Ischemic Events Following Percutaneous Coronary Intervention - A Prespecified Secondary Analysis of the TAILOR-PCI Randomised Trial

Speaker: Doctor B. Ingraham (Rochester, US)

Thumbnail

Access the full session

Late-Breaking Science - Innovations in drug treatment

Speakers: Professor D. Bhatt, Professor F. Zannad, Doctor S. Koudstaal, Doctor B. Ingraham
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations